高级检索
    周云, 王娜娜, 周霞, 冯敏. 湿性老年性黄斑变性病人视网膜血流的变化对预后判定的指导价值[J]. 蚌埠医科大学学报, 2019, 44(1): 51-53, 57. DOI: 10.13898/j.cnki.issn.1000-2200.2019.01.015
    引用本文: 周云, 王娜娜, 周霞, 冯敏. 湿性老年性黄斑变性病人视网膜血流的变化对预后判定的指导价值[J]. 蚌埠医科大学学报, 2019, 44(1): 51-53, 57. DOI: 10.13898/j.cnki.issn.1000-2200.2019.01.015
    shu
    ZHOU Yun, WANG Na-na, ZHOU Xia, FENG Min. The value of the retinal blood flow change in evaluating the prognosis of patients with wet age-related macular degeneration[J]. Journal of Bengbu Medical University, 2019, 44(1): 51-53, 57. DOI: 10.13898/j.cnki.issn.1000-2200.2019.01.015
    Citation: ZHOU Yun, WANG Na-na, ZHOU Xia, FENG Min. The value of the retinal blood flow change in evaluating the prognosis of patients with wet age-related macular degeneration[J]. Journal of Bengbu Medical University, 2019, 44(1): 51-53, 57. DOI: 10.13898/j.cnki.issn.1000-2200.2019.01.015
    shu

    湿性老年性黄斑变性病人视网膜血流的变化对预后判定的指导价值

    The value of the retinal blood flow change in evaluating the prognosis of patients with wet age-related macular degeneration

      摘要
    • 摘要:
      目的探讨湿性老年性黄斑变性病人视网膜血流的变化对预后判定的指导价值。
      方法选择湿性老年性黄斑变性病人72例（72眼）作为观察组，同期选择健康体检的老年人72名（72眼）作为对照组，对照组在体检时进行视网膜血流检测；观察组均给予玻璃体腔注射曲雷珠单抗治疗，在治疗前后进行视网膜血流的超声检测，观察预后情况。
      结果观察组治疗后患眼动脉和视网膜中央动脉的舒张末期血流速度和收缩期峰值血流速度均明显高于治疗前（P < 0.05~P < 0.01），与对照组比较差异均无统计学意义（P > 0.05）；观察组治疗前后的阻力指数与对照组比较差异均无统计学意义（P > 0.05）。观察组治疗后的最佳矫正视力明显好于治疗前（P < 0.01）；治疗期间的并发症发生率为6.9%，经过对症处理后均好转。直线相关分析显示患眼动脉和视网膜中央动脉的舒张末期血流速度和收缩期峰值血流速度均与预后视力状况呈负相关关系（P < 0.05）。
      结论湿性老年性黄斑变性病人视网膜的血流速度均明显降低，雷珠单抗注射液的应用治疗能有效改善视力与视网膜血流状况，同时视网膜的血流速度变化对病人疗效评估具有较重要的临床价值。

       

      Abstract:
      ObjectiveTo investigate the value of the retinal blood flow change in evaluating the prognosis of patients with wet age-related macular degeneration.
      MethodsSeventy-two patients with wet age-related macular degeneration(72 eyes) and 72 healthy elderly(72 eyes) were divided into the observation group and control group, respectively.The vitreous chamber in observation group was injected with ranibizumab.The retinal blood flow levels in observation group before and after treatment, which in control group were observed using the ultrasound the physical examination.
      ResultsThe diastolic velocity and peak systolic velocity of ophthalmic artery and central retinal artery in observation group after treatment were significantly higher than before treatment(P < 0.05 to P < 0.01), and the difference of which between two groups was not statistically significant(P > 0.05).The differences between the resistance index in observation group before and after treatment, and resistance index in control group were not statistically significant(P > 0.05).The best corrected visual acuity in observation group after treatment was significantly better than before treatment(P < 0.01).The incidence rate of complications during treatment was 6.9%, and the complication was improved after symptomatic treatment.Linear correlation analysis showed that the diastolic velocity, peak systolic velocity of ophthalmic artery and central retinal artery were negatively correlated with the vision of prognosis(P < 0.05).
      ConclusionsThe retinal blood flow velocity in patients with wet age-related macular degeneration significantly decreases, the ranibizumab injection can effectively improve the vision and retinal blood flow of patients, and the change of retinal blood flow velocity has an important value on assessing the prognosis of patients in clinic.

       

      • HTML全文
      • 参考文献(18)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回